Global Botanical and Plant Derived Drugs Market Insights, Forecast to 2029

Publisher Name :
Date: 14-Aug-2023
No. of pages: 88
Inquire Before Buying

Botanical drugs are those drugs which are derived from medicinal plants. Plant derived drugs are combination of botanical as well as other approved drugs that contains plant materials, synthetic and semi synthetic substances. Botanical drugs consist of vegetable material, algae and macroscopic fungi. They are used in treatment of various diseases, such as central nervous system disorders, cardiovascular diseases, infectious diseases and respiratory diseases. Botanical drugs are available in various forms, such as pills, tablets, capsules and injections. Botanical drugs, such as aescin, adoniside, atropine and berberine, are derived from plants. These drugs are used as an important component of traditional medicine and therapies, such as homeopathy and ayurvedic medicines. Some of the major classes of plant drugs are terpenes, steroids, glycosides and phenols.

Market Analysis and Insights: Global Botanical and Plant Derived Drugs Market

The global Botanical and Plant Derived Drugs market is projected to grow from US$ 30010 million in 2023 to US$ 37100 million by 2029, at a Compound Annual Growth Rate (CAGR) of 3.6% during the forecast period.

Globally, increased usage of botanical drugs as an alternative to synthetic medicine and increasing prevalence of various chronic diseases are some of the major drivers for growth of botanical and plant derived drugs. In addition, low cost of botanical drugs and technological advancement in production procedure of botanical drugs are also supporting in growth of botanical and plant derived drugs market. However, stringent laws and regulations for approval of botanical drugs is a key restraint for botanical and plant derived drugs market.

Report Includes

This report presents an overview of global market for Botanical and Plant Derived Drugs market size. Analyses of the global market trends, with historic market revenue data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.

This report researches the key producers of Botanical and Plant Derived Drugs, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Botanical and Plant Derived Drugs, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Botanical and Plant Derived Drugs revenue, market share and industry ranking of main companies, data from 2018 to 2023. Identification of the major stakeholders in the global Botanical and Plant Derived Drugs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by type and by application, revenue, and growth rate, from 2018 to 2029. Evaluation and forecast the market size for Botanical and Plant Derived Drugs revenue, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including Abott Laboratories, Bayer Healthcare, Bionova, Bristol Myers and Curapharm, etc.

By Company

- Abott Laboratories

- Bayer Healthcare

- Bionova

- Bristol Myers

- Curapharm

Segment by Type

- Tablets

- Capsules

- Pills

- Injections

Segment by Application

- Hospital Pharmacies

- Retail Pharmacies

- Online Pharmacies

- Drug Stores

By Region

- North America

- - United States

- - Canada

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Russia

- - Nordic Countries

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Australia

- - Rest of Asia

- Latin America

- - Mexico

- - Brazil

- - Rest of Latin America

- Middle East, Africa, and Latin America

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Revenue of Botanical and Plant Derived Drugs in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Botanical and Plant Derived Drugs companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: North America by type, by application and by country, revenue for each segment.

Chapter 7: Europe by type, by application and by country, revenue for each segment.

Chapter 8: China by type and by application revenue for each segment.

Chapter 9: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, revenue for each segment.

Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Botanical and Plant Derived Drugs revenue, gross margin, and recent development, etc.

Chapter 12: Analyst's Viewpoints/Conclusions

Global Botanical and Plant Derived Drugs Market Insights, Forecast to 2029

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Botanical and Plant Derived Drugs Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Tablets
1.2.3 Capsules
1.2.4 Pills
1.2.5 Injections
1.3 Market by Application
1.3.1 Global Botanical and Plant Derived Drugs Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.3.5 Drug Stores
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Botanical and Plant Derived Drugs Market Perspective (2018-2029)
2.2 Global Botanical and Plant Derived Drugs Growth Trends by Region
2.2.1 Botanical and Plant Derived Drugs Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Botanical and Plant Derived Drugs Historic Market Size by Region (2018-2023)
2.2.3 Botanical and Plant Derived Drugs Forecasted Market Size by Region (2024-2029)
2.3 Botanical and Plant Derived Drugs Market Dynamics
2.3.1 Botanical and Plant Derived Drugs Industry Trends
2.3.2 Botanical and Plant Derived Drugs Market Drivers
2.3.3 Botanical and Plant Derived Drugs Market Challenges
2.3.4 Botanical and Plant Derived Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Botanical and Plant Derived Drugs by Players
3.1.1 Global Botanical and Plant Derived Drugs Revenue by Players (2018-2023)
3.1.2 Global Botanical and Plant Derived Drugs Revenue Market Share by Players (2018-2023)
3.2 Global Botanical and Plant Derived Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Botanical and Plant Derived Drugs, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Botanical and Plant Derived Drugs Market Concentration Ratio
3.4.1 Global Botanical and Plant Derived Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Botanical and Plant Derived Drugs Revenue in 2022
3.5 Global Key Players of Botanical and Plant Derived Drugs Head office and Area Served
3.6 Global Key Players of Botanical and Plant Derived Drugs, Product and Application
3.7 Global Key Players of Botanical and Plant Derived Drugs, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Botanical and Plant Derived Drugs Breakdown Data by Type
4.1 Global Botanical and Plant Derived Drugs Historic Market Size by Type (2018-2023)
4.2 Global Botanical and Plant Derived Drugs Forecasted Market Size by Type (2024-2029)
5 Botanical and Plant Derived Drugs Breakdown Data by Application
5.1 Global Botanical and Plant Derived Drugs Historic Market Size by Application (2018-2023)
5.2 Global Botanical and Plant Derived Drugs Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Botanical and Plant Derived Drugs Market Size (2018-2029)
6.2 North America Botanical and Plant Derived Drugs Market Size by Type
6.2.1 North America Botanical and Plant Derived Drugs Market Size by Type (2018-2023)
6.2.2 North America Botanical and Plant Derived Drugs Market Size by Type (2024-2029)
6.2.3 North America Botanical and Plant Derived Drugs Market Share by Type (2018-2029)
6.3 North America Botanical and Plant Derived Drugs Market Size by Application
6.3.1 North America Botanical and Plant Derived Drugs Market Size by Application (2018-2023)
6.3.2 North America Botanical and Plant Derived Drugs Market Size by Application (2024-2029)
6.3.3 North America Botanical and Plant Derived Drugs Market Share by Application (2018-2029)
6.4 North America Botanical and Plant Derived Drugs Market Size by Country
6.4.1 North America Botanical and Plant Derived Drugs Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Botanical and Plant Derived Drugs Market Size by Country (2018-2023)
6.4.3 North America Botanical and Plant Derived Drugs Market Size by Country (2024-2029)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Botanical and Plant Derived Drugs Market Size (2018-2029)
7.2 Europe Botanical and Plant Derived Drugs Market Size by Type
7.2.1 Europe Botanical and Plant Derived Drugs Market Size by Type (2018-2023)
7.2.2 Europe Botanical and Plant Derived Drugs Market Size by Type (2024-2029)
7.2.3 Europe Botanical and Plant Derived Drugs Market Share by Type (2018-2029)
7.3 Europe Botanical and Plant Derived Drugs Market Size by Application
7.3.1 Europe Botanical and Plant Derived Drugs Market Size by Application (2018-2023)
7.3.2 Europe Botanical and Plant Derived Drugs Market Size by Application (2024-2029)
7.3.3 Europe Botanical and Plant Derived Drugs Market Share by Application (2018-2029)
7.4 Europe Botanical and Plant Derived Drugs Market Size by Country
7.4.1 Europe Botanical and Plant Derived Drugs Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Botanical and Plant Derived Drugs Market Size by Country (2018-2023)
7.4.3 Europe Botanical and Plant Derived Drugs Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Botanical and Plant Derived Drugs Market Size (2018-2029)
8.2 China Botanical and Plant Derived Drugs Market Size by Type
8.2.1 China Botanical and Plant Derived Drugs Market Size by Type (2018-2023)
8.2.2 China Botanical and Plant Derived Drugs Market Size by Type (2024-2029)
8.2.3 China Botanical and Plant Derived Drugs Market Share by Type (2018-2029)
8.3 China Botanical and Plant Derived Drugs Market Size by Application
8.3.1 China Botanical and Plant Derived Drugs Market Size by Application (2018-2023)
8.3.2 China Botanical and Plant Derived Drugs Market Size by Application (2024-2029)
8.3.3 China Botanical and Plant Derived Drugs Market Share by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Botanical and Plant Derived Drugs Market Size (2018-2029)
9.2 Asia Botanical and Plant Derived Drugs Market Size by Type
9.2.1 Asia Botanical and Plant Derived Drugs Market Size by Type (2018-2023)
9.2.2 Asia Botanical and Plant Derived Drugs Market Size by Type (2024-2029)
9.2.3 Asia Botanical and Plant Derived Drugs Market Share by Type (2018-2029)
9.3 Asia Botanical and Plant Derived Drugs Market Size by Application
9.3.1 Asia Botanical and Plant Derived Drugs Market Size by Application (2018-2023)
9.3.2 Asia Botanical and Plant Derived Drugs Market Size by Application (2024-2029)
9.3.3 Asia Botanical and Plant Derived Drugs Market Share by Application (2018-2029)
9.4 Asia Botanical and Plant Derived Drugs Market Size by Region
9.4.1 Asia Botanical and Plant Derived Drugs Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Botanical and Plant Derived Drugs Market Size by Region (2018-2023)
9.4.3 Asia Botanical and Plant Derived Drugs Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Botanical and Plant Derived Drugs Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Botanical and Plant Derived Drugs Market Size by Type
10.2.1 Middle East, Africa, and Latin America Botanical and Plant Derived Drugs Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Botanical and Plant Derived Drugs Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Botanical and Plant Derived Drugs Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Botanical and Plant Derived Drugs Market Size by Application
10.3.1 Middle East, Africa, and Latin America Botanical and Plant Derived Drugs Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Botanical and Plant Derived Drugs Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Botanical and Plant Derived Drugs Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Botanical and Plant Derived Drugs Market Size by Country
10.4.1 Middle East, Africa, and Latin America Botanical and Plant Derived Drugs Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Botanical and Plant Derived Drugs Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Botanical and Plant Derived Drugs Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Abott Laboratories
11.1.1 Abott Laboratories Company Details
11.1.2 Abott Laboratories Business Overview
11.1.3 Abott Laboratories Botanical and Plant Derived Drugs Introduction
11.1.4 Abott Laboratories Revenue in Botanical and Plant Derived Drugs Business (2018-2023)
11.1.5 Abott Laboratories Recent Developments
11.2 Bayer Healthcare
11.2.1 Bayer Healthcare Company Details
11.2.2 Bayer Healthcare Business Overview
11.2.3 Bayer Healthcare Botanical and Plant Derived Drugs Introduction
11.2.4 Bayer Healthcare Revenue in Botanical and Plant Derived Drugs Business (2018-2023)
11.2.5 Bayer Healthcare Recent Developments
11.3 Bionova
11.3.1 Bionova Company Details
11.3.2 Bionova Business Overview
11.3.3 Bionova Botanical and Plant Derived Drugs Introduction
11.3.4 Bionova Revenue in Botanical and Plant Derived Drugs Business (2018-2023)
11.3.5 Bionova Recent Developments
11.4 Bristol Myers
11.4.1 Bristol Myers Company Details
11.4.2 Bristol Myers Business Overview
11.4.3 Bristol Myers Botanical and Plant Derived Drugs Introduction
11.4.4 Bristol Myers Revenue in Botanical and Plant Derived Drugs Business (2018-2023)
11.4.5 Bristol Myers Recent Developments
11.5 Curapharm
11.5.1 Curapharm Company Details
11.5.2 Curapharm Business Overview
11.5.3 Curapharm Botanical and Plant Derived Drugs Introduction
11.5.4 Curapharm Revenue in Botanical and Plant Derived Drugs Business (2018-2023)
11.5.5 Curapharm Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Botanical and Plant Derived Drugs Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of Tablets
Table 3. Key Players of Capsules
Table 4. Key Players of Pills
Table 5. Key Players of Injections
Table 6. Global Botanical and Plant Derived Drugs Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 7. Global Botanical and Plant Derived Drugs Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 8. Global Botanical and Plant Derived Drugs Market Size by Region (2018-2023) & (US$ Million)
Table 9. Global Botanical and Plant Derived Drugs Market Share by Region (2018-2023)
Table 10. Global Botanical and Plant Derived Drugs Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 11. Global Botanical and Plant Derived Drugs Market Share by Region (2024-2029)
Table 12. Botanical and Plant Derived Drugs Market Trends
Table 13. Botanical and Plant Derived Drugs Market Drivers
Table 14. Botanical and Plant Derived Drugs Market Challenges
Table 15. Botanical and Plant Derived Drugs Market Restraints
Table 16. Global Botanical and Plant Derived Drugs Revenue by Players (2018-2023) & (US$ Million)
Table 17. Global Botanical and Plant Derived Drugs Revenue Share by Players (2018-2023)
Table 18. Global Top Botanical and Plant Derived Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Botanical and Plant Derived Drugs as of 2022)
Table 19. Global Botanical and Plant Derived Drugs Industry Ranking 2021 VS 2022 VS 2023
Table 20. Global 5 Largest Players Market Share by Botanical and Plant Derived Drugs Revenue (CR5 and HHI) & (2018-2023)
Table 21. Global Key Players of Botanical and Plant Derived Drugs, Headquarters and Area Served
Table 22. Global Key Players of Botanical and Plant Derived Drugs, Product and Application
Table 23. Global Key Players of Botanical and Plant Derived Drugs, Product and Application
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Botanical and Plant Derived Drugs Market Size by Type (2018-2023) & (US$ Million)
Table 26. Global Botanical and Plant Derived Drugs Revenue Market Share by Type (2018-2023)
Table 27. Global Botanical and Plant Derived Drugs Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 28. Global Botanical and Plant Derived Drugs Revenue Market Share by Type (2024-2029)
Table 29. Global Botanical and Plant Derived Drugs Market Size by Application (2018-2023) & (US$ Million)
Table 30. Global Botanical and Plant Derived Drugs Revenue Share by Application (2018-2023)
Table 31. Global Botanical and Plant Derived Drugs Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 32. Global Botanical and Plant Derived Drugs Revenue Share by Application (2024-2029)
Table 33. North America Botanical and Plant Derived Drugs Market Size by Type (2018-2023) & (US$ Million)
Table 34. North America Botanical and Plant Derived Drugs Market Size by Type (2024-2029) & (US$ Million)
Table 35. North America Botanical and Plant Derived Drugs Market Size by Application (2018-2023) & (US$ Million)
Table 36. North America Botanical and Plant Derived Drugs Market Size by Application (2024-2029) & (US$ Million)
Table 37. North America Botanical and Plant Derived Drugs Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 38. North America Botanical and Plant Derived Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 39. North America Botanical and Plant Derived Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 40. Europe Botanical and Plant Derived Drugs Market Size by Type (2018-2023) & (US$ Million)
Table 41. Europe Botanical and Plant Derived Drugs Market Size by Type (2024-2029) & (US$ Million)
Table 42. Europe Botanical and Plant Derived Drugs Market Size by Application (2018-2023) & (US$ Million)
Table 43. Europe Botanical and Plant Derived Drugs Market Size by Application (2024-2029) & (US$ Million)
Table 44. Europe Botanical and Plant Derived Drugs Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 45. Europe Botanical and Plant Derived Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 46. Europe Botanical and Plant Derived Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 47. China Botanical and Plant Derived Drugs Market Size by Type (2018-2023) & (US$ Million)
Table 48. China Botanical and Plant Derived Drugs Market Size by Type (2024-2029) & (US$ Million)
Table 49. China Botanical and Plant Derived Drugs Market Size by Application (2018-2023) & (US$ Million)
Table 50. China Botanical and Plant Derived Drugs Market Size by Application (2024-2029) & (US$ Million)
Table 51. Asia Botanical and Plant Derived Drugs Market Size by Type (2018-2023) & (US$ Million)
Table 52. Asia Botanical and Plant Derived Drugs Market Size by Type (2024-2029) & (US$ Million)
Table 53. Asia Botanical and Plant Derived Drugs Market Size by Application (2018-2023) & (US$ Million)
Table 54. Asia Botanical and Plant Derived Drugs Market Size by Application (2024-2029) & (US$ Million)
Table 55. Asia Botanical and Plant Derived Drugs Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 56. Asia Botanical and Plant Derived Drugs Market Size by Region (2018-2023) & (US$ Million)
Table 57. Asia Botanical and Plant Derived Drugs Market Size by Region (2024-2029) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Botanical and Plant Derived Drugs Market Size by Type (2018-2023) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Botanical and Plant Derived Drugs Market Size by Type (2024-2029) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Botanical and Plant Derived Drugs Market Size by Application (2018-2023) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Botanical and Plant Derived Drugs Market Size by Application (2024-2029) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Botanical and Plant Derived Drugs Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 63. Middle East, Africa, and Latin America Botanical and Plant Derived Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 64. Middle East, Africa, and Latin America Botanical and Plant Derived Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 65. Abott Laboratories Company Details
Table 66. Abott Laboratories Business Overview
Table 67. Abott Laboratories Botanical and Plant Derived Drugs Product
Table 68. Abott Laboratories Revenue in Botanical and Plant Derived Drugs Business (2018-2023) & (US$ Million)
Table 69. Abott Laboratories Recent Developments
Table 70. Bayer Healthcare Company Details
Table 71. Bayer Healthcare Business Overview
Table 72. Bayer Healthcare Botanical and Plant Derived Drugs Product
Table 73. Bayer Healthcare Revenue in Botanical and Plant Derived Drugs Business (2018-2023) & (US$ Million)
Table 74. Bayer Healthcare Recent Developments
Table 75. Bionova Company Details
Table 76. Bionova Business Overview
Table 77. Bionova Botanical and Plant Derived Drugs Product
Table 78. Bionova Revenue in Botanical and Plant Derived Drugs Business (2018-2023) & (US$ Million)
Table 79. Bionova Recent Developments
Table 80. Bristol Myers Company Details
Table 81. Bristol Myers Business Overview
Table 82. Bristol Myers Botanical and Plant Derived Drugs Product
Table 83. Bristol Myers Revenue in Botanical and Plant Derived Drugs Business (2018-2023) & (US$ Million)
Table 84. Bristol Myers Recent Developments
Table 85. Curapharm Company Details
Table 86. Curapharm Business Overview
Table 87. Curapharm Botanical and Plant Derived Drugs Product
Table 88. Curapharm Revenue in Botanical and Plant Derived Drugs Business (2018-2023) & (US$ Million)
Table 89. Curapharm Recent Developments
Table 90. Research Programs/Design for This Report
Table 91. Key Data Information from Secondary Sources
Table 92. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Botanical and Plant Derived Drugs Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 2. Global Botanical and Plant Derived Drugs Market Share by Type: 2022 VS 2029
Figure 3. Tablets Features
Figure 4. Capsules Features
Figure 5. Pills Features
Figure 6. Injections Features
Figure 7. Global Botanical and Plant Derived Drugs Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 8. Global Botanical and Plant Derived Drugs Market Share by Application: 2022 VS 2029
Figure 9. Hospital Pharmacies Case Studies
Figure 10. Retail Pharmacies Case Studies
Figure 11. Online Pharmacies Case Studies
Figure 12. Drug Stores Case Studies
Figure 13. Botanical and Plant Derived Drugs Report Years Considered
Figure 14. Global Botanical and Plant Derived Drugs Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 15. Global Botanical and Plant Derived Drugs Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 16. Global Botanical and Plant Derived Drugs Market Share by Region: 2022 VS 2029
Figure 17. Global Botanical and Plant Derived Drugs Market Share by Players in 2022
Figure 18. Global Top Botanical and Plant Derived Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Botanical and Plant Derived Drugs as of 2022)
Figure 19. The Top 10 and 5 Players Market Share by Botanical and Plant Derived Drugs Revenue in 2022
Figure 20. North America Botanical and Plant Derived Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. North America Botanical and Plant Derived Drugs Market Share by Type (2018-2029)
Figure 22. North America Botanical and Plant Derived Drugs Market Share by Application (2018-2029)
Figure 23. North America Botanical and Plant Derived Drugs Market Share by Country (2018-2029)
Figure 24. United States Botanical and Plant Derived Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. Canada Botanical and Plant Derived Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Europe Botanical and Plant Derived Drugs Market Size YoY (2018-2029) & (US$ Million)
Figure 27. Europe Botanical and Plant Derived Drugs Market Share by Type (2018-2029)
Figure 28. Europe Botanical and Plant Derived Drugs Market Share by Application (2018-2029)
Figure 29. Europe Botanical and Plant Derived Drugs Market Share by Country (2018-2029)
Figure 30. Germany Botanical and Plant Derived Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. France Botanical and Plant Derived Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. U.K. Botanical and Plant Derived Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Italy Botanical and Plant Derived Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Russia Botanical and Plant Derived Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Nordic Countries Botanical and Plant Derived Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. China Botanical and Plant Derived Drugs Market Size YoY (2018-2029) & (US$ Million)
Figure 37. China Botanical and Plant Derived Drugs Market Share by Type (2018-2029)
Figure 38. China Botanical and Plant Derived Drugs Market Share by Application (2018-2029)
Figure 39. Asia Botanical and Plant Derived Drugs Market Size YoY (2018-2029) & (US$ Million)
Figure 40. Asia Botanical and Plant Derived Drugs Market Share by Type (2018-2029)
Figure 41. Asia Botanical and Plant Derived Drugs Market Share by Application (2018-2029)
Figure 42. Asia Botanical and Plant Derived Drugs Market Share by Region (2018-2029)
Figure 43. Japan Botanical and Plant Derived Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. South Korea Botanical and Plant Derived Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. China Taiwan Botanical and Plant Derived Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Southeast Asia Botanical and Plant Derived Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. India Botanical and Plant Derived Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. Australia Botanical and Plant Derived Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 49. Middle East, Africa, and Latin America Botanical and Plant Derived Drugs Market Size YoY (2018-2029) & (US$ Million)
Figure 50. Middle East, Africa, and Latin America Botanical and Plant Derived Drugs Market Share by Type (2018-2029)
Figure 51. Middle East, Africa, and Latin America Botanical and Plant Derived Drugs Market Share by Application (2018-2029)
Figure 52. Middle East, Africa, and Latin America Botanical and Plant Derived Drugs Market Share by Country (2018-2029)
Figure 53. Brazil Botanical and Plant Derived Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 54. Mexico Botanical and Plant Derived Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 55. Turkey Botanical and Plant Derived Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 56. Saudi Arabia Botanical and Plant Derived Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 57. Israel Botanical and Plant Derived Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 58. GCC Countries Botanical and Plant Derived Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 59. Abott Laboratories Revenue Growth Rate in Botanical and Plant Derived Drugs Business (2018-2023)
Figure 60. Bayer Healthcare Revenue Growth Rate in Botanical and Plant Derived Drugs Business (2018-2023)
Figure 61. Bionova Revenue Growth Rate in Botanical and Plant Derived Drugs Business (2018-2023)
Figure 62. Bristol Myers Revenue Growth Rate in Botanical and Plant Derived Drugs Business (2018-2023)
Figure 63. Curapharm Revenue Growth Rate in Botanical and Plant Derived Drugs Business (2018-2023)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
  • Global High Content Screening Market Research Report 2024 (Status and Outlook)
    Published: 15-Dec-2023        Price: US 3200 Onwards        Pages: 124
    Report Overview: High-content screening (HCS) or high-content analysis (HCA) (also known as cellomics), is a set of analytical techniques that is applied in genetic research and drug discovery processes in order to recognize elements such as peptides, small molecules, or genetic materials (such as RNAi) that have the potential to modify the phenotype of a cell in a certain manner. High-content screening employs a set of analytical procedures such as multi-parameter image processing, automa......
  • Global Fragment-Based Drug Discovery Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 07-Dec-2023        Price: US 3380 Onwards        Pages: 108
    Market Overview of Global Fragment-Based Drug Discovery market: According to our latest research, the global Fragment-Based Drug Discovery market looks promising in the next 5 years. As of 2022, the global Fragment-Based Drug Discovery market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysi......
  • Global High Throughput Screening Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 28-Nov-2023        Price: US 3380 Onwards        Pages: 111
    Market Overview of Global High Throughput Screening market: According to our latest research, the global High Throughput Screening market looks promising in the next 5 years. As of 2022, the global High Throughput Screening market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. High throughput screening refers to the experimental method based on molecular and cellular levels, using microplate......
  • Global High Content Screening Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 09-Nov-2023        Price: US 3380 Onwards        Pages: 111
    Market Overview of Global High Content Screening market: According to our latest research, the global High Content Screening market looks promising in the next 5 years. As of 2022, the global High Content Screening market was estimated at USD 579.78 million, and it's anticipated to reach USD 1216.18 million in 2028, with a CAGR of 13.14% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the ......
  • Global Botanical and Plant Derived Drugs Market Insights, Forecast to 2029
    Published: 14-Aug-2023        Price: US 4900 Onwards        Pages: 88
    Botanical drugs are those drugs which are derived from medicinal plants. Plant derived drugs are combination of botanical as well as other approved drugs that contains plant materials, synthetic and semi synthetic substances. Botanical drugs consist of vegetable material, algae and macroscopic fungi. They are used in treatment of various diseases, such as central nervous system disorders, cardiovascular diseases, infectious diseases and respiratory diseases. Botanical drugs are available in vari......
  • Global High Content Screening Market Insights, Forecast to 2029
    Published: 11-Aug-2023        Price: US 4900 Onwards        Pages: 110
    High-content screening (HCS) or high-content analysis (HCA) (also known as cellomics), is a set of analytical techniques that is applied in genetic research and drug discovery processes in order to recognize elements such as peptides, small molecules, or genetic materials (such as RNAi) that have the potential to modify the phenotype of a cell in a certain manner. High-content screening employs a set of analytical procedures such as multi-parameter image processing, automated microscopy, fluores......
  • Global High Throughput Screening Market Insights: Impact of COVID-19 and Future Expectations to 2028
    Published: 27-Jun-2023        Price: US 3260 Onwards        Pages: 115
    High throughput screening refers to the experimental method based on molecular and cellular levels, using microplate as an experimental tool carrier, performing the test process with an automated operating system, collecting experimental results data with sensitive and rapid detection instruments, and processing experiments with computer analysis. Data, testing tens of millions of samples at the same time, and supporting the running technical system with the corresponding database, it is charact......
  • Global Fragment-based Drug Discovery Market Insights, Forecast to 2029
    Published: 31-May-2023        Price: US 4900 Onwards        Pages: 111
    The introduction of new techniques into the existing fragment-based drug discovery practices have created significant reductions in time and cost, driving the demand for such practices. Market Analysis and Insights: Global Fragment-based Drug Discovery Market The global Fragment-based Drug Discovery market is projected to grow from US$ 365.8 million in 2023 to US$ 533.8 million by 2029, at a Compound Annual Growth Rate (CAGR) of 6.5% during the forecast period. The US & Cana......
  • High Throughput Screening Market Growth Analysis Report - Latest Trends, Driving Factors and Key Players Research to 2030
    Published: 05-May-2023        Price: US 4150 Onwards        Pages: 146
    The study predicts the short term and long term trends that can shape up the future of the High Throughput Screening market including the COVID-19 pandemic implications for High Throughput Screenings industry. The report presents market size forecasts across types, applications, end users and countries across regions. Strategic imperatives for development managers, decision makers and industry professionals including market trends, drivers, challenges, five forces analysis, insights on markets a......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs